Search Results - "Gower-Rousseau, C."

Quality of life of inflammatory bowel diseases patients in france with EQ-5D-5 L: the QALY-MICI study.

Authors: Sarter, H. Kirschgesner, J. Beaugerie, L. et al.

Source: Quality of Life Research. Feb2025, Vol. 34 Issue 2, p405-416. 12p.

Subjects: Quality of life, Inflammatory bowel diseases, Visual analog scale, Ulcerative colitis, Crohn's disease, Patient reported outcome measures

Geographic Terms: France

Incidence and associated factors of cetuximab-induced hypersensitivity infusion reactions in 1392 cancer patients treated in four French areas: a possible association with Lyme disease?

Authors: Dupont, M Carlier, Claire Gower-Rousseau, C et al.

Source: BMC Cancer. 11/25/2022, Vol. 22 Issue 1, p1-11. 11p.

Review article: the natural history of paediatric-onset ulcerative colitis in population-based studies.

Authors: Fumery, M. Duricova, D. Gower‐Rousseau, C. et al.

Source: Alimentary Pharmacology & Therapeutics. Feb2016, Vol. 43 Issue 3, p346-355. 10p. 1 Diagram, 4 Charts.

Mortalité et cancers dans une cohorte en population générale de patients atteints de maladie de Crohn à début pédiatrique.

Authors: Michaud, L. Gower-Rousseau, C. Savoye, G. et al.

Source: Archives de Pédiatrie. May2013, Vol. 20 Issue 5, p539-539. 1p.

P632 Long-term outcome of paediatric-onset ulcerative colitis: early years are shaping the future

Authors: Gower-Rousseau, C. Salleron, J. Turck, D. et al.

Source: Journal of Crohn's & Colitis. Feb2013 Supplement, Vol. 7, pS264-S264. 1p.

OP04 Mortality and cancer in paediatric inflammatory bowel disease: A population-based study

Authors: Gower-Rousseau, C. Savoye, G. Turck, D. et al.

Source: Journal of Crohn's & Colitis. Feb2012 Supplement 1, Vol. 6, pS2-S2. 1p.

Editorial: post‐operative complications in elderly onset inflammatory bowel disease—what is surgery, what is disease, and what is delay of surgery? Authors’ reply.

Authors: Savoye, G. Fumery, M. Gower‐Rousseau, C.

Source: Alimentary Pharmacology & Therapeutics. Aug2018, Vol. 48 Issue 3, p384-385. 2p.

Author's reply.

Authors: Baldé, M. Gower-Rousseau, C. Turck, D. et al.

Source: Gut (0017-5749). Oct2005, Vol. 54 Issue 10, p1501-1501. 1/5p.

Post‐operative complications in elderly onset inflammatory bowel disease: a population‐based study.

Authors: Sacleux, S.‐C. Sarter, H. Fumery, M. et al.

Source: Alimentary Pharmacology & Therapeutics. Jun2018, Vol. 47 Issue 12, p1652-1660. 9p. 5 Charts.

Systematic review and meta-analysis: assessment of factors affecting disability in inflammatory bowel disease and the reliability of the inflammatory bowel disease disability index.

Authors: Lo, B. Prosberg, M. V. Gluud, L. L. et al.

Source: Alimentary Pharmacology & Therapeutics. Jan2018, Vol. 47 Issue 1, p6-15. 10p.

Uric acid levels are independent of anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn’s disease: A reappraisal of the role of S. cerevisiae in this setting.

Authors: Sendid, B. Jawhara, S. Sarter, H. et al.

Source: Virulence. 2018, Vol. 9 Issue 1, p1224-1229. 6p.

Incidence and Phenotype at Diagnosis of Very-early-onset Compared with Later-onset Paediatric Inflammatory Bowel Disease: A Population-based Study [1988–2011].

Authors: Bequet, E. Sarter, H. Fumery, M. et al.

Source: Journal of Crohn's & Colitis. May2017, Vol. 11 Issue 5, p519-526. 8p. 2 Charts, 3 Graphs, 1 Map.

Systematic review: fertility in non-surgically treated inflammatory bowel disease.

Authors: Tavernier, N. Fumery, M. Peyrin‐Biroulet, L. et al.

Source: Alimentary Pharmacology & Therapeutics. Oct2013, Vol. 38 Issue 8, p847-853. 7p. 1 Diagram, 4 Charts.

The changing pattern of Crohn's disease incidence in northern France: a continuing increase in the 10- to 19-year-old age bracket (1988-2007).

Authors: Chouraki, V. Savoye, G. Dauchet, L. et al.

Source: Alimentary Pharmacology & Therapeutics. May2011, Vol. 33 Issue 10, p1133-1142. 10p. 2 Charts, 4 Graphs, 1 Map.

The RAGE signaling pathway is involved in intestinal inflammation and represents a promising therapeutic target for Inflammatory Bowel Diseases.

Authors: Body-Malapel, M. Djouina, M. Waxin, C. et al.

Source: Mucosal Immunology (1933-0219). Mar2019, Vol. 12 Issue 2, p468-478. 11p.

P321 Recurrence of Crohn's disease after definitive stoma: A retrospective study in 83 patients

Authors: Koriche, D. Salleron, J. Gower-Rousseau, C. et al.

Source: Journal of Crohn's & Colitis. Feb2012 Supplement 1, Vol. 6, pS138-S138. 1p.

P213 - Concurrence of inflammatory bowel disease and multiple sclerosis in general population: frequency, phenotypes and clinical course

Authors: Buzaglo, G. Salleron, J. Gower-Rousseau, C. et al.

Source: Journal of Crohn's & Colitis. Feb2009, Vol. 3 Issue 1, pS94-S95. 0p.

Environmental risk factors in paediatric inflammatory bowel diseases: a population based case control study.

Authors: Baron, S. Turck, D. Leplat, C. et al.

Source: Gut (0017-5749). Mar2005, Vol. 54 Issue 3, p357-363. 7p. 5 Charts.

CARD4/NOD1 is not involved in inflammatory bowel disease.

Authors: Zouali, H. Lesage, S. Merlin, F. et al.

Source: Gut (0017-5749). Jan2003, Vol. 52 Issue 1, p71. 4p. 3 Charts.

The changing epidemiology of paediatric inflammatory bowel disease: authors' reply.

Authors: Chouraki, V. Turck, D. Colombel, J.‐F. et al.

Source: Alimentary Pharmacology & Therapeutics. Jun2011, Vol. 33 Issue 12, p1381-1382. 2p.